MOESM5 of Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study

  • Christian Torp-Pedersen (Ophavsperson)
  • Jonas Bjerring Olesen (Ophavsperson)
  • Anders Bonde (Ophavsperson)
  • Laila Staerk (Ophavsperson)
  • Nicholas Carlson (Ophavsperson)
  • Emma Kirstine Laugesen (Ophavsperson)
  • Anne-Lise Kamper (Bidrager)
  • Gunnar Gislason (Ophavsperson)

Datasæt

Beskrivelse

Additional file 5. Hazard ratio according to type of oral anticoagulation among atrial fibrillation patients with CKD when not censoring at shift or discontinuation of oral anticoagulation.
Dato for tilgængelighed2019
ForlagFigshare

Citationsformater